Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

  • Mahamadou A. Thera,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Ogobara K. Doumbo,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Drissa Coulibaly,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Dapa A. Diallo,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Abdoulaye K. Kone,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Ando B. Guindo,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Karim Traore,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Alassane Dicko,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Issaka Sagara,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Mahamadou S. Sissoko,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Mounirou Baby,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Mady Sissoko,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Issa Diarra,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Amadou Niangaly,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Amagana Dolo,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Modibo Daou,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Sory I. Diawara,

    Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • D. Gray Heppner,

    Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  • V. Ann Stewart,

    Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  • Evelina Angov,

    Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  • Elke S. Bergmann-Leitner,

    Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  • David E. Lanar,

    Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  • Sheetij Dutta,

    Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  • Lorraine Soisson,

    Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D. C., United States of America

  • Carter L. Diggs,

    Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D. C., United States of America

  • Amanda Leach,

    Affiliation World Wide Clinical Development – Malaria Vaccines, GlaxoSmithKline Biologicals, Rixensart, Belgium

  • Alex Owusu,

    Affiliation World Wide Clinical Development – Malaria Vaccines, GlaxoSmithKline Biologicals, Rixensart, Belgium

  • Marie-Claude Dubois,

    Affiliation World Wide Clinical Development – Malaria Vaccines, GlaxoSmithKline Biologicals, Rixensart, Belgium

  • Joe Cohen,

    Affiliation World Wide Clinical Development – Malaria Vaccines, GlaxoSmithKline Biologicals, Rixensart, Belgium

  • Jason N. Nixon,

    Current address: Department of Radiology, University of Washington, Seattle, Washington, United States of America,

    Affiliation Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  • Aric Gregson,

    Current address: Division of Infectious Diseases, Department of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America

    Affiliation Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  • Shannon L. Takala,

    Affiliation Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  • Kirsten E. Lyke,

    Affiliation Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  •  [ ... ],
  • Christopher V. Plowe

    To whom correspondence should be addressed. E-mail: cplowe@medicine.umaryland.edu

    Affiliation Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.